CDKN2A and adrenal cortex carcinoma: For disease specific survival (DSS), high mRNA levels of CDKN2A correlated with ACC, COAD, DLBC (Lymphoid Neoplasm Diffuse Large B), KIRC, MESO, PCPG and UCEC tumors, with p-values of 0.007, 0.017, 0.049, 0.006, 0.001, 0.015, and 0.001, respectively.